Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Toxicologic Pathology|February 14, 2012
Giant cell tumor of bonelike lesion in a Trp53 mutant mouseEnrico Radaelli, Alessandra Rustighi, Eugenio ScanzianiFrontiers in Oncology|March 16, 2019
Oncogenic Hijacking of the PIN1 Signaling NetworkAlessandro Zannini, Alessandra Rustighi, Elena Campaner, et al.Biochimica Et Biophysica Acta|February 3, 2015
Interaction of p53 with prolyl isomerases: Healthy and unhealthy relationshipsFiamma Mantovani, Alessandro Zannini, Alessandra Rustighi, et al.Biochemistry|January 23, 2002
A polypyrimidine/polypurine tract within the Hmga2 minimal promoter: a common feature of many growth-related genesAlessandra Rustighi, Michela A Tessari, Fulvia Vascotto, et al.Journal of Toxicologic Pathology|February 15, 2014
Immunohistochemical Characterization of a Renal Nephroblastoma in a Trp53-mutant and Prolyl Isomerase 1-deficient MouseVittoria Castiglioni, Marcella De Maglie, Roberta Queliti, et al.Cell Death and Differentiation|November 12, 2016
PIN1 in breast development and cancer: a clinical perspectiveAlessandra Rustighi, Alessandro Zannini, Elena Campaner, et al.Nucleic Acids Research|February 28, 2007
The second AT-hook of the architectural transcription factor HMGA2 is determinant for nuclear localization and functionGiacomo Cattaruzzi, Sandro Altamura, Michela A Tessari, et al.Biochemistry|March 26, 2003
During apoptosis of tumor cells HMGA1a protein undergoes methylation: identification of the modification site by mass spectrometryRiccardo Sgarra, Francesca Diana, Cristina Bellarosa, et al.Blood|November 15, 2007
Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cellsPaola Secchiero, Federica Corallini, Erika Rimondi, et al.FEBS Letters|September 11, 2004
Nuclear phosphoproteins HMGA and their relationship with chromatin structure and cancerRiccardo Sgarra, Alessandra Rustighi, Michela A Tessari, et al.Pageof 4